Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: Data from an international, collaborative initiative of the Trisomy 21 Research Society

Detalles Bibliográficos
Autores principales: Valentini, D., Carfi, A., Di Paola, A., Yarci-Carrión, A., Villani, Alberto, Real de Asúa, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940466/
https://www.ncbi.nlm.nih.gov/pubmed/36813120
http://dx.doi.org/10.1016/j.jinf.2023.02.021
_version_ 1784891083561369600
author Valentini, D.
Carfi, A.
Di Paola, A.
Yarci-Carrión, A.
Villani, Alberto
Real de Asúa, D.
author_facet Valentini, D.
Carfi, A.
Di Paola, A.
Yarci-Carrión, A.
Villani, Alberto
Real de Asúa, D.
author_sort Valentini, D.
collection PubMed
description
format Online
Article
Text
id pubmed-9940466
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-99404662023-02-21 Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: Data from an international, collaborative initiative of the Trisomy 21 Research Society Valentini, D. Carfi, A. Di Paola, A. Yarci-Carrión, A. Villani, Alberto Real de Asúa, D. J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2023-04 2023-02-20 /pmc/articles/PMC9940466/ /pubmed/36813120 http://dx.doi.org/10.1016/j.jinf.2023.02.021 Text en © 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Valentini, D.
Carfi, A.
Di Paola, A.
Yarci-Carrión, A.
Villani, Alberto
Real de Asúa, D.
Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: Data from an international, collaborative initiative of the Trisomy 21 Research Society
title Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: Data from an international, collaborative initiative of the Trisomy 21 Research Society
title_full Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: Data from an international, collaborative initiative of the Trisomy 21 Research Society
title_fullStr Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: Data from an international, collaborative initiative of the Trisomy 21 Research Society
title_full_unstemmed Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: Data from an international, collaborative initiative of the Trisomy 21 Research Society
title_short Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: Data from an international, collaborative initiative of the Trisomy 21 Research Society
title_sort factor associated with sars-cov-2 vaccination serological efficacy in adolescents and adults with down syndrome: data from an international, collaborative initiative of the trisomy 21 research society
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940466/
https://www.ncbi.nlm.nih.gov/pubmed/36813120
http://dx.doi.org/10.1016/j.jinf.2023.02.021
work_keys_str_mv AT valentinid factorassociatedwithsarscov2vaccinationserologicalefficacyinadolescentsandadultswithdownsyndromedatafromaninternationalcollaborativeinitiativeofthetrisomy21researchsociety
AT carfia factorassociatedwithsarscov2vaccinationserologicalefficacyinadolescentsandadultswithdownsyndromedatafromaninternationalcollaborativeinitiativeofthetrisomy21researchsociety
AT dipaolaa factorassociatedwithsarscov2vaccinationserologicalefficacyinadolescentsandadultswithdownsyndromedatafromaninternationalcollaborativeinitiativeofthetrisomy21researchsociety
AT yarcicarriona factorassociatedwithsarscov2vaccinationserologicalefficacyinadolescentsandadultswithdownsyndromedatafromaninternationalcollaborativeinitiativeofthetrisomy21researchsociety
AT villanialberto factorassociatedwithsarscov2vaccinationserologicalefficacyinadolescentsandadultswithdownsyndromedatafromaninternationalcollaborativeinitiativeofthetrisomy21researchsociety
AT realdeasuad factorassociatedwithsarscov2vaccinationserologicalefficacyinadolescentsandadultswithdownsyndromedatafromaninternationalcollaborativeinitiativeofthetrisomy21researchsociety

Ejemplares similares